{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T03:31:09Z","timestamp":1764905469518},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T00:00:00Z","timestamp":1341532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1475-2875-11-225","type":"journal-article","created":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T16:30:50Z","timestamp":1341592250000},"source":"Crossref","is-referenced-by-count":24,"title":["Pharmacovigilance of artemether-lumefantrine in pregnant women followed until delivery in Rwanda"],"prefix":"10.1186","volume":"11","author":[{"given":"Stephen","family":"Rulisa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Kaligirwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Agaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corine","family":"Karema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra F","family":"Mens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,6]]},"reference":[{"key":"2123_CR1","volume-title":"Rwanda National Health Sector Policy -2005","author":"Government of Rwanda (GOR)","year":"2005","unstructured":"Government of Rwanda (GOR): Rwanda National Health Sector Policy -2005. 2005, GOR, http:\/\/www.eac.int\/health\/index.php?option=com_docman&Itemid=47 , Accessed 1 October 2011"},{"key":"2123_CR2","volume-title":"WHO Guidelines for the Treatment of Malaria","author":"WHO","year":"2010","unstructured":"WHO: WHO Guidelines for the Treatment of Malaria. 2010, World Health Organization, Geneva, Second","edition":"Second"},{"key":"2123_CR3","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2147\/TCRM.S5375","volume":"5","author":"S Ehrhardt","year":"2009","unstructured":"Ehrhardt S, Meyer CG: Artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria. Ther Clin Risk Manag. 2009, 5: 805-815.","journal-title":"Ther Clin Risk Manag"},{"issue":"Suppl 1","key":"2123_CR4","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/1475-2875-8-S1-S5","volume":"8","author":"M Makanga","year":"2009","unstructured":"Makanga M, Krudsood S: The clinical efficacy of artemether\/lumefantrine (Coartem). Malar J. 2009, 8 (Suppl 1): S5-10.1186\/1475-2875-8-S1-S5.","journal-title":"Malar J"},{"issue":"Suppl 1","key":"2123_CR5","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1186\/1475-2875-8-S1-S6","volume":"8","author":"C Falade","year":"2009","unstructured":"Falade C, Manyando C: Safety profile of Coartem: the evidence base. Malar J. 2009, 8 (Suppl 1): S6-10.1186\/1475-2875-8-S1-S6.","journal-title":"Malar J"},{"key":"2123_CR6","volume-title":"Assessment of the safety of Artemisinin compounds in pregnancy","author":"TDR","year":"2006","unstructured":"TDR: Assessment of the safety of Artemisinin compounds in pregnancy. 2006, TDR, http:\/\/whqlibdoc.who.int\/publications\/2007\/9789241596114_eng.pdf , Accessed 10 March 2012"},{"key":"2123_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1475-2875-6-15","volume":"6","author":"S Dellicour","year":"2007","unstructured":"Dellicour S, Hall S, Chandramohan D, Greenwood B: The safety of artemisinins during pregnancy: a pressing question. Malar J. 2007, 6: 15-10.1186\/1475-2875-6-15.","journal-title":"Malar J"},{"key":"2123_CR8","volume-title":"Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals","author":"FDA","year":"2008","unstructured":"FDA: Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals. 2008, FDA, http:\/\/www.fda.gov\/downloads\/RegulatoryInformation\/Guidances\/ucm129524.pdf , Accessed 31 January 2012"},{"key":"2123_CR9","volume-title":"Ethical considerations in biomedical HIV prevention trials: UNAIDS\/WHO guidance document","author":"UNAIDS\/WHO","year":"2007","unstructured":"UNAIDS\/WHO: Ethical considerations in biomedical HIV prevention trials: UNAIDS\/WHO guidance document. 2007, http:\/\/data.unaids.org\/pub\/manual\/2007\/jc1349_ethics_2_11_07_en.pdf , Accessed 15 May 2012"},{"key":"2123_CR10","volume-title":"Guideline on the exposure to medicinal products during pregnancy: need for post-authorisation data","author":"EMEA","year":"2005","unstructured":"EMEA: Guideline on the exposure to medicinal products during pregnancy: need for post-authorisation data. 2005, EMEA, http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Regulatory_and_procedural_guideline\/2009\/11\/WC500011303.pdf , Accessed 3 June 2012"},{"key":"2123_CR11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/bdrb.20027","volume":"71","author":"RL Clark","year":"2004","unstructured":"Clark RL, White TE, Clode A, Gaunt I, Winstanley P, Ward SA: Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit. Birth Defects Res B Dev Reprod Toxicol. 2004, 71: 380-394. 10.1002\/bdrb.20027.","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"2123_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.reprotox.2005.05.005","volume":"21","author":"M Longo","year":"2006","unstructured":"Longo M, Zanoncelli S, Manera D, Brughera M, Colombo P, Lansen J, Mazue G, Gomes M, Taylor WR, Olliaro P: Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitro. Reprod Toxicol. 2006, 21: 83-93. 10.1016\/j.reprotox.2005.05.005.","journal-title":"Reprod Toxicol"},{"key":"2123_CR13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4269\/ajtmh.2007.77.181","volume":"77","author":"F Nosten","year":"2007","unstructured":"Nosten F, White NJ: Artemisinin-based combination treatment of falciparum malaria. AmJTrop Med Hyg. 2007, 77: 181-192.","journal-title":"AmJTrop Med Hyg"},{"key":"2123_CR14","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1371\/journal.pmed.0050187","volume":"5","author":"S Dellicour","year":"2008","unstructured":"Dellicour S, ter Kuile FO, Stergachis A: Pregnancy exposure registries for assessing antimalarial drug safety in pregnancy in malaria-endemic countries. PLoS Med. 2008, 5: e187-10.1371\/journal.pmed.0050187.","journal-title":"PLoS Med"},{"key":"2123_CR15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1651-2227.2006.tb02379.x","volume":"450","author":"WHO Multicentre Growth Reference Study Group. WHO Motor Development Study","year":"2006","unstructured":"WHO Multicentre Growth Reference Study Group. WHO Motor Development Study: Windows of achievement for six gross motor development milestones. Acta Paediatrica Supplement. 2006, 450: 86-95.","journal-title":"Acta Paediatrica Supplement"},{"key":"2123_CR16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4269\/ajtmh.2001.64.28","volume":"64","author":"RW Steketee","year":"2001","unstructured":"Steketee RW, Nahlen BL, Parise ME, Menendez C: The burden of malaria in pregnancy in malaria-endemic areas. AmJTrop Med Hyg. 2001, 64: 28-35.","journal-title":"AmJTrop Med Hyg"},{"key":"2123_CR17","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/j.1471-0528.2005.00714.x","volume":"112","author":"CJ Whitty","year":"2005","unstructured":"Whitty CJ, Edmonds S, Mutabingwa TK: Malaria in pregnancy. BJOG. 2005, 112: 1189-1195. 10.1111\/j.1471-0528.2005.00714.x.","journal-title":"BJOG"},{"key":"2123_CR18","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1371\/journal.pmed.0050253","volume":"5","author":"R McGready","year":"2008","unstructured":"McGready R, Tan SO, Ashley EA, Pimanpanarak M, Viladpai-Nguen J, Phaiphun L, Wustefeld K, Barends M, Laochan N, Keereecharoen L: A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated Plasmodium falciparum treatment in pregnancy. PLoS Med. 2008, 5: e253-10.1371\/journal.pmed.0050253.","journal-title":"PLoS Med"},{"key":"2123_CR19","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S1473-3099(10)70202-4","volume":"10","author":"P Piola","year":"2010","unstructured":"Piola P, Nabasumba C, Turyakira E, Dhorda M, Lindegardh N, Nyehangane D, Snounou G, Ashley EA, McGready R, Nosten F: Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial. Lancet Infect Dis. 2010, 10: 762-769. 10.1016\/S1473-3099(10)70202-4.","journal-title":"Lancet Infect Dis"},{"key":"2123_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1179\/136485909X398285","volume":"103","author":"I Adam","year":"2009","unstructured":"Adam I, Elhassan EM, Omer EM, Abdulla MA, Mahgoub HM, Adam GK: Safety of artemisinins during early pregnancy, assessed in 62 Sudanese women. Ann Trop Med Parasitol. 2009, 103: 205-210. 10.1179\/136485909X398285.","journal-title":"Ann Trop Med Parasitol"},{"key":"2123_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/1475-2875-9-249","volume":"9","author":"C Manyando","year":"2010","unstructured":"Manyando C, Mkandawire R, Puma L, Sinkala M, Mpabalwani E, Njunju E, Gomes M, Ribeiro I, Walter V, Virtanen M: Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia. Malar J. 2010, 9: 249-10.1186\/1475-2875-9-249.","journal-title":"Malar J"},{"key":"2123_CR22","volume-title":"Integrated Approach to Reducing Malaria Related Morbidity and Mortality in Rwanda","author":"National Malaria Control Programme (NMCP) -Rwanda","year":"2008","unstructured":"National Malaria Control Programme (NMCP) -Rwanda: Integrated Approach to Reducing Malaria Related Morbidity and Mortality in Rwanda. 2008, NMCP, www.afro.who.int\/index.php?option=com_docman&task , Accessed 12 December 2011"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-11-225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1475-2875-11-225\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-11-225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T14:16:39Z","timestamp":1714140999000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-11-225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,6]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2123"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-11-225","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,6]]},"article-number":"225"}}